Lymphogranuloma venereum in the United Kingdom

Sexually Transmitted Infections

Volumn 81, Issue 2, 2005, Pages 97-98

  French, Patrick ^a   Ison, C A ^b   Macdonald, N ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ERYTHROMYCIN;

ANTIBIOTIC THERAPY; CHLAMYDIA TRACHOMATIS; EDITORIAL; HEPATITIS C; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOGRANULOMA VENEREUM; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; UNITED KINGDOM;

CHLAMYDIA TRACHOMATIS; GREAT BRITAIN; HOMOSEXUALITY, MALE; HUMANS; LYMPHOGRANULOMA VENEREUM; MALE;

EID: 17144409056     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.015263     Document Type: Editorial

References (12)

1. Götz H, Nieuwenhuis R, Ossewaarde T, et al. Preliminary report of an outbreak of lymphogranuloma venereum in homosexual men in the Netherlands, with implications for other countries in western Europe. Eurosurveillance Weekly 2004;8(4):22 Jan 2004.
2. Vandenbruaene M. Uitbraak van Lymphogranuloma Venereum in Antwepen en Rotterdam. Epidemiologisch Bulletin van de Vlaamse Gemeenschap 2004;47:4-6.
3. Robert Koch-Institut. Zum gehäuften Auftreten von Lymphogranuloma Venereum in Hamburg im Jahr 2003. Epidemiologisches Bulletin 2004;25:18 June 2004.
4. Institut de Veille Sanitaire. Emergence de la Lymphogranulomatose vénérienne rectale en France:cas estimés au 31 mars 2004. Synthése réalisée le 1er Juin, 2004.
5. New York City Department of Health and Mental Hygiene. Two New York City residents diagnosed with rare sexually transmitted infection; same strain found in Europe. Press release, 2 February 2005 (available on www.nyc.gov/html/doh/ html/public/press05/pr011-05.html).
6. Meyer T, Arndt R, von Krosigk A, et al. Repeated detection of lymphogranuloma venereum caused by Chlamydia trachomatis L2 in homosexual men in Hamburg (letter). Sex Transm Infect 2005;81:91-4.
7. Health Protection Agency. Enhanced surveillance of lymphogranuloma venereum (LGV) in England. Commun Dis Rep CDR Wkly [serial online] 2004;14(41): News (available at/www.hpa.org. uk/cdr/PDFfiles/2004/cdr4104.pdf).
8. Health Protection Agency. Initial results of enhanced surveillance for lymphogranuloma venereum (LGV) in England Commun Dis Rep CDR Wkly [serial online] 2005;15(5): News (available at www.hpa.org.uk/cdr/archives/archive05/ News/news0405.htm#botulism).
9. Macdonald N, Ison C, Martin I, et al. Initial results of enhanced surveillance for lymphogranuloma venereum (LGV) in England. Eurosurveillance 2005;10:20. January 2005 (available at www. eurosurveillance.org/ew/2005/050127. asp).
10. Quinn TC, Goodall SE, Mrtichian E, et al. Chlamydia trachomatis proctitis. N Engl J Med 1981;305:195-200.
11. Mabey D. Peeling. Lymphogranuloma venereum. Sex Transm Infect 2002;78:90-2.
12. Clinical Effectiveness Group. National guideline for the management of lymphogranuloma venereum. Sex Transm Infect 1999;75(Suppl 1):S40-2.